{
    "Trade/Device Name(s)": [
        "Simplexa\u2122 C. difficile Universal Direct",
        "SimplexaTM C. difficile Universal Direct"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K113433",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110012",
        "K081920"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "OMN"
    ],
    "Summary Letter Date": "April 3, 2012",
    "Summary Letter Received Date": "April 4, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.2660"
    ],
    "Regulation Name(s)": [
        "Microorganism differentiation and identification device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin B gene (tcdB)"
    ],
    "Specimen Type(s)": [
        "Liquid stool",
        "Unformed stool"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "3M Integrated Cycler"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time polymerase chain reaction (PCR)",
        "Fluorescent probe-primer amplification and detection"
    ],
    "Methodologies": [
        "Real-time PCR",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Focus Diagnostics Simplexa\u2122 C. difficile Universal Direct real-time PCR assay for detection of C. difficile toxin B gene in stool samples",
    "Indications for Use Summary": "A real-time PCR assay intended for use on the 3M Integrated Cycler instrument for the detection of toxigenic Clostridium difficile toxin B gene (tcdB) in liquid or unformed stool samples from individuals suspected of C. difficile infection, aiding in the diagnosis of Clostridium difficile associated disease (CDAD)",
    "fda_folder": "Microbiology"
}